Substrate
business

FundaMental Pharma Names Dr. Hans Eriksson Chief Medical Officer

FundaMental Pharma GmbH appointed Dr. Hans Eriksson as Chief Medical Officer on June 2, 2026. Eriksson previously led clinical programs at AstraZeneca, Lundbeck, Compass Pathways and HMNC Brain Health.

Benzinga
manilatimes.net
2 sources·Jun 2, 3:30 AM·1m read
FundaMental Pharma Names Dr. Hans Eriksson Chief Medical Officerrediff.com
Audio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.

FundaMental Pharma GmbH announced the appointment of Dr. Hans Eriksson as Chief Medical Officer on June 2, 2026. The company develops dual-acting N-methyl-D-aspartate receptor modulators for treatment-resistant depression. Eriksson has more than 25 years of clinical development experience and contributed to eight late-phase depression programs, three of which received regulatory approval for major depressive disorder.

Background on Dr.

Before that role, he was Chief Medical Officer at Compass Pathways and oversaw clinical development of a psilocybin candidate for treatment-resistant depression. Earlier positions include senior clinical research and leadership roles at AstraZeneca, where he served as global medical lead for Seroquel, Seroquel XR and TC5214.

Pharma is a preclinical-stage biopharmaceutical company based in Heidelberg, Germany. The appointment is intended to support the company's progress toward first-in-human development of its lead candidate.

Transparency

Confidence65%

2 independent outlets report the same core facts. This score blends how many outlets corroborate, their editorial tier, and how closely their facts agree — it measures corroboration, not proof.

Story details

Related Stories

Anthropic Reaches Near-Profitability, $965 Billion Valuation Within Five Yearsfoxbusiness.com
business10 hrs ago

Anthropic Reaches Near-Profitability, $965 Billion Valuation Within Five Years

Anthropic filed paperwork with U.S. regulators on Monday for an initial public offering planned later this year. Private investors recently valued the company above $965 billion.

BBC News
WA
FR
3 sources
Amazon Moves Prime Day 2026 to June 23-26 and Adds Alexa AI Shopping Toolsforbes.com
business4 hrs ago

Amazon Moves Prime Day 2026 to June 23-26 and Adds Alexa AI Shopping Tools

Amazon will run its annual Prime Day sales event from June 23 through June 26. The four-day promotion includes new Alexa AI features and a focus on groceries and household essentials.

forbes.com
TechCrunch
2 sources
Amazon Expands Prime Day to Four Days June 23-26 With Grocery Discountsnbcnews.com
business8 hrs ago

Amazon Expands Prime Day to Four Days June 23-26 With Grocery Discounts

Amazon will run its annual Prime Day sale from June 23 through June 26. The four-day event will emphasize groceries and household essentials amid record-low U.S. consumer sentiment.

cnbc.com
The Verge
thenextweb.com
rte.ie
4 sources